Skip to content
The AstraZeneca Saga episode artwork

Mar 26, 2021 22 min

The AstraZeneca Saga

from What Next: TBD | Tech, power, and the future

Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval. By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout? Guest: Peter Aldhous, science reporter at Buzzfeed News Host Lizzie O’Leary Need to set up your Slate Plus feed? If you subscribed through Slate.com, check out our FAQ at slate.com/podcastfaqs for easy instructions. Members subscribed via Apple Podcasts get automatic access—no setup required.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

The AstraZeneca Saga

0:00 22:49

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of What Next: TBD | Tech, power, and the future?

This episode is 22 minutes long.

When was this What Next: TBD | Tech, power, and the future episode published?

This episode was published on March 26, 2021.

Can I download this What Next: TBD | Tech, power, and the future episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.